These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2574855)

  • 1. A second polymorphism identified by a fragment co-amplified with c-Ki-ras.
    Heighway J
    Nucleic Acids Res; 1989 Dec; 17(24):10515. PubMed ID: 2574855
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolation of a human genomic fragment, co-amplified with c-Ki-ras, that affects plasmid supercoiling in E. coli.
    Heighway J; Geurts van Kessel AH
    Nucleic Acids Res; 1987 Apr; 15(8):3411-20. PubMed ID: 3033603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TaqI polymorphism within the c-Ha-ras-1 VTR is associated with melanoma.
    Hayward NK; Nancarrow DJ; Parsons PG; Kidson C; Ellem KA
    Hum Genet; 1989 Nov; 83(4):395-6. PubMed ID: 2572539
    [No Abstract]   [Full Text] [Related]  

  • 4. PCR assay for a polymorphic TaqI site in the human K-ras-2 gene on chromosome 12p (KRAS2).
    Abrams ES; Shtatland T; Lerman LS
    Nucleic Acids Res; 1991 Sep; 19(17):4795. PubMed ID: 1679926
    [No Abstract]   [Full Text] [Related]  

  • 5. StuI RFLP in the human ABL locus.
    Baumann R; Smith M
    Nucleic Acids Res; 1990 Feb; 18(3):693. PubMed ID: 1968633
    [No Abstract]   [Full Text] [Related]  

  • 6. Isochromosome 12p in non-seminoma cell lines: karyologic amplification of c-ki-ras2 without point-mutational activation.
    Dmitrovsky E; Murty VV; Moy D; Miller WH; Nanus D; Albino AP; Samaniego F; Bosl G; Chaganti RS
    Oncogene; 1990 Apr; 5(4):543-8. PubMed ID: 2183156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of proto-oncogene c-Ki-ras amplification and overexpression in the malignancy of Y-1 adrenocortical tumor cells.
    Kimura E; Armelin HA
    Braz J Med Biol Res; 1988; 21(2):189-201. PubMed ID: 3060206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification of protooncogenes in surgical specimens of human lung carcinomas.
    Shiraishi M; Noguchi M; Shimosato Y; Sekiya T
    Cancer Res; 1989 Dec; 49(23):6474-9. PubMed ID: 2573414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two polymorphisms of the FOS oncogene.
    Siewertsen MA; Barker DF; Cox DW
    Nucleic Acids Res; 1990 Oct; 18(20):6174. PubMed ID: 1978288
    [No Abstract]   [Full Text] [Related]  

  • 11. BsmI polymorphism in N-ras intron I (RASN).
    Heighway J
    Nucleic Acids Res; 1991 Feb; 19(3):682. PubMed ID: 1672756
    [No Abstract]   [Full Text] [Related]  

  • 12. An SstI RFLP at the C-Kit oncogene locus (KIT).
    Curtis D
    Nucleic Acids Res; 1991 Mar; 19(6):1352. PubMed ID: 1709489
    [No Abstract]   [Full Text] [Related]  

  • 13. Anonymous genomic fragment co-amplified with c-Ki-ras 2 detects frequent polymorphism (pK42).
    Heighway J; Geurts van Kessel AH
    Nucleic Acids Res; 1986 Nov; 14(21):8700. PubMed ID: 2878416
    [No Abstract]   [Full Text] [Related]  

  • 14. Amplification and enhanced expression of the c-Ki-ras2 protooncogene in human embryonal carcinomas.
    Wang LC; Vass W; Gao CL; Chang KS
    Cancer Res; 1987 Aug; 47(15):4192-8. PubMed ID: 2886216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased frequency of specific alleles of the c-Ha-ras gene in Japanese cancer patients.
    Honda K; Ishizaki K; Ikenaga M; Toguchida J; Inamoto T; Tanaka K; Ozawa K
    Hum Genet; 1988 Aug; 79(4):297-300. PubMed ID: 2900800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple genetic alterations in distal and proximal colorectal cancer.
    Delattre O; Olschwang S; Law DJ; Melot T; Remvikos Y; Salmon RJ; Sastre X; Validire P; Feinberg AP; Thomas G
    Lancet; 1989 Aug; 2(8659):353-6. PubMed ID: 2569552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism of the human c-abl gene: relation to incidence and course of chronic myelogenous leukemia.
    Daniel L; Ahmed CM; Bloodgood RS; Kidd JR; Castiglione CM; Duttagupta S; Lebowitz P
    Oncogene; 1987 May; 1(2):193-200. PubMed ID: 2894000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MspI and DraI polymorphisms at the ERBA beta locus on chromosome 3p.
    Brauch H; Latif F; Baylin S; Nelkin BD; Hosoe S; Daniel L; Glenn G; Danko I; Bradley WE; Orcutt ML
    Nucleic Acids Res; 1990 May; 18(9):2833. PubMed ID: 1692616
    [No Abstract]   [Full Text] [Related]  

  • 19. DdeI polymorphism within sequence encoding 3' untranslated region of c-Ki-ras2 (KRAS2).
    Heighway J
    Nucleic Acids Res; 1991 Sep; 19(18):5092. PubMed ID: 1681498
    [No Abstract]   [Full Text] [Related]  

  • 20. PCR detection of an MboI polymorphism in the ERBB2 (HER2; NEU) gene on chromosome 17q11.2-q12.
    Hall JM; King MC
    Nucleic Acids Res; 1991 May; 19(9):2515. PubMed ID: 1675005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.